Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma

Figure 8

Prognostic value of nine IPGRs in HCC patients based on nomogram plots. (a) Clinical features (T, grade, and age) and risk score were analyzed to assess the survival time at 1, 3, 5, and 7 years for HCC patients. (b) Clinical features (stage, grade, and age) and risk score were analyzed to assess the survival time at 1, 3, 5, and 7 years for HCC patients.

(a)

(b)